Summer Sale
50% off Premium Yearly
00days
00hrs
00mins
00secs
NASDAQ:IBB
Ishares Nasdaq Biotechnology (IBB)
177.00
+3.36 (1.94%)
as of Jun 22, 2026, 8:00:00 pm Market Open.
49 watching
Financials 
Technical Analysis 0
BUY
COMMENT
An example of a sector that has been considered to be expensive for the better part of 3-4 years. Not sure of their specific holdings but would imagine they have Biogenic, Biodex, Celgene, etc. This is an example of something he continues to own but doesn’t pretend to know enough about some of their individual companies. A perfect example of companies that you would want to own inside an ETF structure. Thinks it continues to go higher.
E.T.F.'s
TOP PICK
Nasdaq Biotechnology ETF, which has a seasonal strength from June 23 two the 2nd week of September. This is because of a series of healthcare conferences that happen at this time of year.
Don VialouxOwned
E.T.F.'s
PAST TOP PICK
TOP PICK
Really good valuation at under 16X PE. Large diversification. This gives you a play into the area of pharmaceutical. Big pharma is running out of pipeline and the companies in the biotech space are very attractive acquisition candidates.
Vinny CatalanoOwned
E.T.F.'s
'%20fill='%23ffffff'%3e%3cg%20id='Pager'%20transform='translate(423.000000,%201755.000000)'%3e%3cpath%20d='M243.295367,17.286474%20C243.68919,16.9045087%20244.327703,16.9045087%20244.721525,17.286474%20L249,21.4361302%20L253.278475,17.286474%20C253.672297,16.9045087%20254.31081,16.9045087%20254.704633,17.286474%20C255.098456,17.6684393%20255.098456,18.2877274%20254.704633,18.6696927%20L249.35654,23.856763%20C249.159628,24.0477457%20248.840372,24.0477457%20248.64346,23.856763%20L243.295367,18.6696927%20C242.901544,18.2877274%20242.901544,17.6684393%20243.295367,17.286474%20Z'%20id='Path'%20transform='translate(249.000000,%2020.500000)%20scale(-1,%201)%20rotate(-90.000000)%20translate(-249.000000,%20-20.500000)%20'%3e%3c/path%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
Chart shows the trend is upward. Outperforming the market and above its 20 day moving average. Everything looks great on a technical basis. Seasonally, this usually does very well from around the latter part of June right through until September. A lot of this positive movement has to do with a series of healthcare conferences, which are held where biotech companies announce new results and new research.